Purification and characterization of an endogenous protein modulator of radioligand binding to "peripheral-type" benzodiazepine receptors and dihydropyridine ca2+-channel antagonist binding sites

Charles R. Mantione, Mark E. Goldman, Brian Martin, Gordon T. Bolger, Hartmut W.M. Lueddens, Steven M. Paul, Phil Skolnick

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

Acidified extracts of rat antral stomach chromatographed on octadecylsilane cartridges contained material that inhibited the binding of [3H]Ro 5-4864 (4'-chlorodiazepam) and [3H]nitrenidipine to "peripheral-type" benzodiazepine receptors and dihydropyridine Ca2+-channel antagonist binding sites respectively. This material reduced the apparent affinites of both radioligands without significantly affecting the maximum number of binding sites. In contrast, the binding of [3H]diazepam, [3H]Ro 15-1788 (ethyl-8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo [1,5a][1,4]benzodiazepine-3-carboxylate), and [3H]3-carbomethoxy-β-carboline to "brain-type" benzodiazepine receptors and [3H]dihydroalprenolol binding to β-adrenergic receptors were unaffected by this material. Subsequent column chromatography on hydroxylapatite purified this material by > 2000-fold. This semi-purified substance was resolved by reverse phase HPLC as one u.v. adsorbing peak that inhibited both [3H]Ro 5-4864 and [3H]nitrendipine binding. The activity of this 16,000 dalton substance was destroyed completely by both heat treatment and pronase and partially reduced by trypsin. Furthermore, the inhibitory activity of this substance was enhanced by Ca2+ in a concentration-dependent fashion (0.1 to 10 mM). Comparison of TLC scans of 2-9,10[3H]dipalmitoyl-phosphatidylcholine incubated with either the HPLC purified material or authentic phospholipase A2(PLA2) (Naja naja) revealed that this substance has enzymatic properties indistinguishable from PLA2. These findings suggest that this endogenous protein may be a PLA2 isoenzyme which may modify both "peripheral-type" benzodiazepine receptors and dihydro-pyridine Ca2+-channel antagonist binding sites.

Original languageEnglish
Pages (from-to)339-347
Number of pages9
JournalBiochemical Pharmacology
Volume37
Issue number2
DOIs
StatePublished - Jan 15 1988

Keywords

  • "peripheral-type" benzodiazepine receptors
  • (4'-chlorodiazepam) 7-chloro-1,3- dihydro-1- methyl- 5- (p-chlorophenyl)- 2H-1,4-benzodiazepine-2-one
  • 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3-isoquinoline carboxamide
  • 3-carbomethoxy-β-carboline
  • PBR
  • PK 11195
  • PLA
  • Ro 15-1788
  • Ro 5-4864
  • TBPS
  • TCA
  • TFA
  • Tris
  • Tris(hydroxymethyl) aminomethane
  • ethyl-8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5a][1,4]benzodiazepine-3-carboxylate
  • phospholipase A
  • t-butyl-bicyclophosphorothionate
  • trichloroacetic acid
  • trifluoroacetic acid
  • β-CCM

Fingerprint

Dive into the research topics of 'Purification and characterization of an endogenous protein modulator of radioligand binding to "peripheral-type" benzodiazepine receptors and dihydropyridine ca2+-channel antagonist binding sites'. Together they form a unique fingerprint.

Cite this